- Home
- ALVO vs BLX Comparison
ALVO vs BLX Comparison
Compare ALVO & BLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALVO | BLX |
|---|---|---|
| Founded | 2013 | 1977 |
| Country | Luxembourg | Panama |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.8B |
| IPO Year | N/A | 1997 |
Fundamental Metrics
Financial Performance| Metric | ALVO | BLX |
|---|---|---|
| Price | $3.96 | $47.23 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $9.25 | N/A |
| AVG Volume (30 Days) | ★ 624.0K | 106.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 5.67% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $20.22 | $13.11 |
| Revenue Next Year | $37.22 | $10.13 |
| P/E Ratio | $18.20 | ★ $8.26 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.65 | $31.14 |
| 52 Week High | $11.85 | $51.99 |
Technical Indicators
Market Signals| Indicator | ALVO | BLX |
|---|---|---|
| Relative Strength Index (RSI) | 35.34 | 43.74 |
| Support Level | N/A | $43.50 |
| Resistance Level | $5.46 | $47.90 |
| Average True Range (ATR) | 0.23 | 1.29 |
| MACD | -0.00 | -0.39 |
| Stochastic Oscillator | 30.69 | 29.34 |
Price Performance
Historical ComparisonAbout ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.
About BLX Banco Latinoamericano de Comercio Exterior S.A.
Banco Latinoamericano de Comercio Exterior SA provides financial solutions to financial institutions, companies, and investors doing business in Latin America, supporting trade and regional integration. The Bank provides foreign trade solutions to a select client base of American financial institutions and corporations and has developed a network of correspondent banking institutions with access to the international capital markets. It has two business segments: the Commercial Business Segment and the Treasury Business Segment. The majority of its revenue is generated from the Commercial Business segment.